Verition Fund Management’s Collegium Pharmaceutical COLL Stock Holding History

Verition Fund Management’s Portfolio COLL Stock Details COLL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-10,604	Closed	-$351K	–	2160
2026 Q1	$351K	Sell	10,604 -16,791	-61%	-$711K	﹤0.01%	1716
2025 Q4	$1.27M	Buy	+27,395	New	+$1.15M	0.01%	1970
2025 Q3	–	Sell	-43,111	Closed	-$1.27M	–	3788
2025 Q2	$1.27M	Buy	43,111 +28,325	+192%	+$808K	0.01%	2288
2025 Q1	$441K	Buy	14,786 +157	+1%	+$4.8K	﹤0.01%	2661
2024 Q4	$419K	Buy	14,629 +587	+4%	+$19.4K	﹤0.01%	2581
2024 Q3	$543K	Buy	14,042 +3,652	+35%	+$130K	﹤0.01%	2270
2024 Q2	$335K	Buy	+10,390	New	+$360K	﹤0.01%	2279

Other funds holding COLL

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Jupiter Topco New York $245B AUM

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Fuller & Thaler Asset Management San Mateo, California $36.7B AUM 74.15% 1-Year Est. Return

Principal Financial Group Des Moines, Iowa $204B AUM 27.99% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

EAM

Eventide Asset Management Boston, Massachusetts $7.48B AUM 104.76% 1-Year Est. Return

Verition Fund Management's COLL Position: Q2 2026 in Review

Verition Fund Management sold out of Collegium Pharmaceutical (COLL) in Q2 2026, closing a stake of 10,604 shares — an estimated $351K sold.

Verition Fund Management first reported a position in COLL in Q2 2024 and held it in 7 quarters. The position peaked at $1.27M in Q2 2025. 279 funds tracked by Wall St. Rank hold COLL as of Q2 2026.

Verition Fund Management reported no remaining Collegium Pharmaceutical position as of Q2 2026 after selling out during the quarter.
Verition Fund Management sold 10,604 Collegium Pharmaceutical shares in Q2 2026, an estimated $351K.
Verition Fund Management first reported a position in Collegium Pharmaceutical in Q2 2024 and held it in 7 quarters.
Verition Fund Management's Collegium Pharmaceutical position peaked at $1.27M in Q2 2025.
279 funds tracked by Wall St. Rank held Collegium Pharmaceutical as of Q2 2026.

Based on Verition Fund Management's 13F filing for Q2 2026, filed 14 Aug 2026.